QuidelOrtho Stock Rises as Q3 Earnings & Revenues Beat Estimates [Yahoo! Finance]
QuidelOrtho Corporation (QDEL)
Last quidelortho corporation earnings: 2/12 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.quidel.com
Company Research
Source: Yahoo! Finance
GAAP loss per share in the quarter was 30 cents compared with 19 cents in the year-ago quarter. QuidelOrtho registered revenues of $727.1 million in the third quarter, which decreased 2.3% year over year on a reported basis and 1.8% at a constant exchange rate (CER). However, the figure beat the Zacks Consensus Estimate by 12.8%. In the third quarter, QuidelOrtho's total recurring revenues, excluding COVID-19-related revenues, instrument revenues and U.S. Donor screening revenues, were $597.9 million (up 0.4% on a reported basis and 0.9% at CER). The company defines recurring revenue as revenues from sales of assays, reagents, consumables and services, excluding instruments. In the third quarter, Respiratory revenues were $165.4 million (down 10.8%, both on a reported basis and at CER). Non-Respiratory revenues were $561.7 million (up 0.6% on a reported basis and 1.2% at CER). QuidelOrtho now derives revenues from five business units — Labs, Immunohematology, Donor Screenin
Show less
Read more
Impact Snapshot
Event Time:
QDEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QDEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QDEL alerts
High impacting QuidelOrtho Corporation news events
Weekly update
A roundup of the hottest topics
QDEL
News
- QuidelOrtho Co. (NASDAQ: QDEL) had its "market perform" rating re-affirmed by analysts at William Blair.MarketBeat
- QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle GroupBusiness Wire
- QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle GroupBusiness Wire
- In Vitro Diagnostics (IVD) Market to Reach USD 126.6 Billion by 2032, at 4.8% CAGR, Driven by Rising Prevalence of Chronic Diseases and Advances in Diagnostic Technologies – S&S Insider [Yahoo! Finance]Yahoo! Finance
- Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law FirmPR Newswire
QDEL
Earnings
- 11/7/24 - Beat
QDEL
Sec Filings
- 11/22/24 - Form 3
- 11/21/24 - Form SC
- 11/21/24 - Form 4
- QDEL's page on the SEC website